I received a master’s degree in biology from the College of William and Mary and a Ph. D. in Biochemistry and Molecular Biology with a focus on translational control and the integrated stress response from the Indiana University School of Medicine. Over my 20+ year Lilly career as a cell and molecular biologist, I have supported small molecule, peptide, and large molecule discovery efforts in the areas of bone formation, osteoporosis, uterine leiomyomas, breast cancer, osteoarthritis, insulin secretion, atherosclerosis, metabolic syndrome, obesity, kidney disease, oncology, immunology, neurodegeneration, and pain. I have been recognized for leadership and implementation of genomic technologies to drive and impact drug discovery to identify and validate new targets for the Lilly portfolio. Over the last several years, I have continued to evaluate new targets for emerging therapeutic modalities. During my career, I have authored or co-authored 29 papers, given presentations at many national and international scientific meetings, and am a co-author on several patents.

AFFILIATIONS:

• Member of OTS Society 2020-2021
• Member of the Society for Investigative Dermatology 2019
• Board Member of a local parish in Pendleton, Indiana, 2016-2017